Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

Employing MRI-targeted biopsy instead of systematic biopsy reduces overdiagnosis of low-grade prostate cancer by more than half, although diagnoses may be delayed among a small minority of patients ...

Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...

Curtis Pettaway, MD, of the University of Texas M.D. Anderson Cancer Center in Houston, and his colleagues recently characterized radical prostatectomy specimens obtained from 37 AA men and 35 white ...

Grade group 1 prostate cancer assessment should include PSA, stage, and disease volume for accurate risk evaluation. Active surveillance is safe for most low-risk patients, but higher-risk features ...

Dear Dr. Roach: A very healthy male friend in his upper 50s has to make a decision whether to accept or decline his very aggressive urologist’s decision to do a biopsy of his prostate. It seems that ...

The global statistics are terrifying. Prostate cancer is the fourth most common cancer in all populations, the second most common cancer among men worldwide, and ranks first in Europe, where a third ...

Dear Dr. Roach: I am a 74-year-old male in relatively good health. The only prescribed medication I take is 5 mg of amlodipine daily. My issue is my PSA score. In 2004, I had a UTI, and the urologist ...

Although sextant biopsy is inadequate and the current reference standard involves a minimum of 12 cores, there is a point of diminishing returns regarding the numbers of cores. We published findings ...